Ani Pharmaceuticals, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$4.9Mgeneral payments (2019-2025)
$17Kresearch payments (2019-2025)
17,790clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Purified Cortrophin Gel $4.2M associated (2023-2025)
- Iluvien $135K associated (2023-2025)
- Yutiq $82K associated (2023-2025)
- Sovuna $15K associated (2023-2025)
- Veregen $7,815 associated (2023-2025)
- Oxistat $3,888 associated (2023-2025)
- Apexicon E $2,557 associated (2023-2025)
- Valsartan $169 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Sudhakar Tumuluri | San Francisco, CA | Rheumatology | $190,993.10 |
| Dhiman Basu | Colleyville, TX | Rheumatology | $125,929.81 |
| Wassim Saikali | Beckley, WV | Rheumatology | $97,259.14 |
| Francis Mah | Pittsburgh, PA | $79,069.98 | |
| Sanjay Chabra | El Paso, TX | Rheumatology | $73,112.97 |
| Jessica Coleman | Beaufort, SC | Nephrology (Internal Medicine) | $73,002.32 |
| Rajkumar Dasgupta | Pasadena, CA | Pulmonary Disease | $67,561.24 |
| Kostas Botsoglou | Cheektowaga, NY | Rheumatology | $67,422.22 |
| Andrew Sulich | Saint Clair Shores, MI | Rheumatology | $67,225.68 |
| Regina Berkovich | West Hollywood, CA | Neurology (Psychiatry & Neurology) | $64,730.98 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.